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INTRODUCTION:  Malignant  mesothelioma  is a rare neoplasm  of  mesothelial  cells  arising  most  frequently
in  the pleura  or  peritoneum  and  less  frequently  in the  liver.
CASE  PRESENTATION:  We  present  a  case  of  primary  hepatic  mesothelioma  of 41  year old  woman.  She
had  no  history  of  asbestos  exposure  or cancer.  Abdominal  computed  tomography  (CT)  showed  21 cm
intrahepatic  mass  in the  right  lobe  with  many  cystic  lesions  and  few small  calciﬁcations.  Pathology
showed  a biphasic  cellular  pattern.  In addition,  the tumor  cells  were  positive  for  Calretinin,  Creatine
Kinase  (CK)5/6,  CK7,  CKAEI  1/3,  Wilms  Tumor  protein  (WT-1),  and  Vimentin,  but were  negative  for  Alpha
Feto protein  (AFP),  Thrombotic  Thrombocytopenic  Purpura  (TTP-1),  Anti-Hepatocyte  Speciﬁc  Antigen
(HSA),  Synaptophysin,  CK20,  and  Homeobox  protein  (CDx-2).
DISCUSSION:  Primary  intrahepatic  mesothelioma  (PIHMM)  is  not  included  in the  classiﬁcation  of the
World  Health  Organization  classiﬁcation  of hepatic  tumors.  Mesothelial  cells  are  not normally  found  in
the liver,  but  some  reported  cases  suggest  it may  grow  from  the  mesothelial  cells  of  the  Glisson’s  capsule.
CONCLUSION:  The  probability  of hepatic  mesothelioma  should  not  be  ruled  out,  even  in  a  young woman
without  a  clear  history  of  asbestos  exposure.
© 2016  The  Author(s).  Published  by Elsevier  Ltd on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open
he CCaccess  article  under  t
. Introduction
Primary malignant mesothelioma of the liver is an extremely
are pathology. It is commonly found in the pleura, peritoneum
nd pericardium. Mesotheliomas are most commonly associated
ith exposure to asbestos [1]. Less common etiology includes MC29
vian virus [2]. Epidemiologic data suggests that genetic predispo-
ition might have an essential role in determining the development
f mesothelioma since the analysis of pedigrees of families affected
y mesotheliomas showed that these mesotheliomas seemed to be
nherited in an autosomal dominant pattern [3].
We are reporting a rare case of a primary intrahepatic mesothe-
ioma in a 41-year-old female patient.
. Case presentationA 41-year old female patient was referred to our institution with
ight hypochondriac pain and dizziness for one month. The pain
as associated with fatigue, weight loss, periodic low-grade fever
∗ Corresponding author at: Associate Professor of Surgery American University of
eirut Medical Center, P.O Box 11-0236, Beirut, Lebanon.
E-mail address: wf07@aub.edu.lb (W.  Faraj).
ttp://dx.doi.org/10.1016/j.ijscr.2016.11.001
210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
and tachycardia. Physical examination revealed a large palpable
mass in the right upper abdomen extending to the pelvis. She had
no history of prior asbestos exposure, cigarette smoking or alcohol
use.
Laboratory examinations revealed anemia with Hb
level = 8.4 g/dL (range Female 12.0–16.0), and Hct% = 27% (range
Female 37.0–46.0). Liver function tests showed elevated alkaline
phosphatase (ALP) = 407 IU/L (range 35–120), gamma-glutamyl
transferase (g-GT) = 211 IU/L (range 10–50) and international nor-
malized ratio (INR) = 1.6 (range 0.8–1.1). The rest of the laboratory
examinations were within normal ranges. Viral markers related to
hepatitis B virus (HBV) and hepatitis C virus (HCV) infection were
negative.
Computed tomography scan (CT scan) revealed a mass in the
liver measuring 21 × 20 × 15.5 cm occupying the right lobe with
multiple cystic lesions and few small calciﬁcations (Figs. 1 and 2).
The mass was reaching the periphery of the liver causing capsu-
lar indentation on the liver with adjacent perihepatic ﬂuid. There
are several arterial feeding collaterals arising from the right hepatic
artery. The enlarged liver is compressing the adjacent bowel loops,
right kidney, right adrenal, and the inferior vena cava. The portal
vein is normal in caliber measuring 11 mm and patent. The pan-
creas, spleen, adrenals, kidneys and bowel loops are unremarkable.
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Coronal Computed Tomography scan. The ﬁgure shows a coronal CT triple
phase scan of the liver displaying a 21 × 20 × 15.5 cm mass occupying the right lobe
with multiple cystic lesions and few small calciﬁcations.
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aig. 2. Transverse Computed Tomography scan. The ﬁgure shows a cross-sectional
can of the mass occupying the right lobe of the liver.
eliac trunk, superior mesenteric artery, and inferior mesenteric
rtery are patent.
The case was discussed in the Tumor Board, and decision was
ade to go for surgery. The patient underwent right hepatectomy
ith cholecystectomy (Fig. 3). She did well postoperatively and was
ischarged on day 10 post surgery.Pathology revealed a biphasic cellular pattern. In areas, the
pithelioid cells were arranged in gland-like structures and in solid
heets. In other areas, the cells were splindled and embedded in
 ﬁbrotic stroma. The cells exhibited mild to moderate cytologicFig. 3. Mass displaying well-circumscribed heterogeneous lesion. The ﬁgure shows
a  24 × 20 × 12 cm mass weighing 4.6 kg. It has a multi-cystic and solid tan-yellow
soft  cut surface.
atypia. Few mitoses and multinucleated giant cells were noted.
Extensive areas of necrosis were present. In addition, the gallblad-
der showed chronic cholecystitis without stones.
Immunohistochemically, tumor cells were positive for Calre-
tinin, CK5/6, CK7, CKAEI 1/3, WT-1, and Vimentin. However, it was
negative for AFP, TTP-1, HSA, Synaptophysin, CK20, and CDx-2.
These ﬁndings were consistent with primary intrahepatic malig-
nant mesothelioma. Surgical margins were free of disease. No
adjuvant chemotherapy was  given.
3. Discussion
Primary intrahepatic mesothelioma (PIHMM) is a very rare
pathology. It is not included in the World Health Organization clas-
siﬁcation of hepatic tumors [4]. Mesothelioma is more common
in men  with a mean age of 58 years [5]. Histomorphologically,
mesotheliomas are classiﬁed into two  types: localized and diffuse.
They can be further classiﬁed into three subtypes: predominantly
epithelioid, sarcomatoid and biphasic types. Within the epithelioid
category, they are arranged according to morphologic variations
such as tubulopapillary and solid patterns.
The differential diagnosis includes several histological types of
tumor; primary and secondary liver neoplasms, such as hepatocel-
lular carcinoma, cholangiocellular carcinoma, and adenocarcinoma
that had metastasized from an unknown site [6,7].
Mesothelial cells are not present in the liver under any normal
condition. It might emerge from other types by transition. However,
there is no evidence of transition yet. Some reported cases suggest
that the primitive tumor may  grow from the mesothelial cells of
the Glisson’s capsule, which eventually invade the liver [8].
A review of eleven cases is summed up in Table 1. The cases
consisted of seven females and four males (2:1), with an age range
of 50–83 years (median: 62 years). Only two  patients (18.1%) had
a history of asbestos exposure, disproving a previous study which
showed that malignant mesothelioma is usually associated with
asbestos exposure (86.8%) [9]. All eleven patients presented with
localized tumor in the liver at the time of the initial diagnosis, and
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Table  1
Characteristics of patients with PIHMM:  PIHMM,  Primary intrahepatic mesothelioma; F, Female; M,  Male; Surg., Surgical; Lt., Left lobe; Rt., Right lobe; N/E, Not Evaluated;
Sp.,  Spindle cells; Ep., Endothelial cells; Bp., Biphasic; BSC, Best Supportive Care; Tx., Treatment; LNR, trans-lymphatic Relapse; DI, Direct Invasion.
Author Age Sex Asbestoses Size(cm) Type Location Tx. Relapse Follow-Up
Kottke-Marchan, 1989 [12] 83 F N/E 15 Sp. Lt. Surg. No 3 months
Di  Blasi, 2004 [13] 61 F N/E 10 Ep. Rt. Surg. Yes 2 years
M.  Buchholz, 2009 [11] 62 F No 5.8 EP. Rt. (S5, S8) Surg. LNR 20 months
Sakasi,  2009 [4] 66 M Yes 4.4 Bp. Rt.(S8) Surg. No 6 month
Gutgement, 2006 [1] 62 M No 5.8 Ep. Rt. Surg. LNR 5 months
Serter,  2014 [14] 56 F No 15 Ep. RT(S4, S7, S8) Surg. No N/E
Serter, 2014 [14] 66 M No Multi Bp. Bilobated Surg. No N/E
Inagaki, 2013 [15] 68 F No 7 Ep. Rt.(S7) BSC N/E 3 months
Lenonarda, 2003 [8] 54 F Yes 12 Ep. Rt. Surg. No 2 months
Dong,  2013 [16] 50 F No Multi Ep. Bilobated Surg. N/E N/E
Kim,  2008 [17] 53 M No 13 Bp. Rt. Surg. DI N/E
Present case 41 F No 24 Bp. Rt.(S5,S6,S7,S8) Surg. No N/E
Table 2
Immunohistochemical phenotypes of PIHMM and conventional mesothelioma.
Author Calretinin CD2-40 CK5/6 CK7 CKAE1/3 WT-1 Vimentin P53
Kottke-Marchan, 1989 [12] N/E N/E N/E N/E N/E N/E + N/E
Di  Blasi, 2004 [13] ± N/E + N/E N/E ± + N/E
M.  Buchholz, 2009 [11] + + - + N/E + ± N/E
Sakasi, 2009 [4] + + + + N/E + + +
Gutgeman, 2006 [1] + + - + N/E + ± +
Serter,  2014 [14] + N/E N/E N/E N/E N/E N/E N/E
Serter,  2014 [14] + N/E + N/E N/E N/E + N/E
Inagaki, 2013 [15] + ± N/E + N/E + + +
Lenonarda, 2003 [8] + N/E N/E N/E + N/E + N/E
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Present case + N/E + 
urgical removal was performed in all of the cases. However, four
ut of the ten patients who underwent surgical removal relapsed
fter surgery. Other authors reported a 55.1% metastasis-associated
alignant mesothelioma at initial diagnosis [10].
Most of the cases reported had a tumor with a median size of
1.2 cm (range 4.4–15 cm). Our patient had the tumor double the
ize of all the reported cases, which was 21 cm in its largest dimen-
ion, making it the largest mesothelioma that has been reported.
urthermore, seven cases were of epithelioid type (63.6%), three
ere biphasic (27.3%) and one case was of sarcomatoid type (9.1%),
hile the prevalence of epithelioid, biphasic and sarcomatoid sub-
ypes in a recent study was 32, 21.7 and 9.8% respectively [11]. The
umor immunohistochemistry of the reviewed cases are summa-
ized in Table 2. We  found the most dominant tumor marker to be
alretinin and Vimentin.
. Conclusion
We  present a very rare case of primary malignant mesothelioma
f the liver found in a young female. Under microscope the mass
howed epithelioid and spindled cells arranged in tri-structure pat-
ern. Further investigation remains to be done on more cases of
rimary intrahepatic mesotheliomas to obtain morphology, prog-
osis and develop an appropriate treatment strategy for this rare
umor.
The work has been reported in line with the SCARE criteria [18].
onsentWritten informed consent was obtained from the patient for
ublication of this case report and accompanying images. A copy
f the written consent is available for review by the Editor-in-Chief
f this journal on request.N/E N/E N/E + N/E
+ N/E N/E N/E N/E
+ + + + N/E
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